.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
US Department of Justice
Federal Trade Commission
Chinese Patent Office
UBS
Medtronic
Chubb
Covington

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Treatment for insomnia
Abstract:A method for the treatment of chronic insomnia is disclosed which involves the administration of low dosages of a compound selected from the pharmaceutically acceptable forms of doxepin, trimipramine, amitriptyline, trazodone and mixtures hereof.
Inventor(s): Kavey; Neil B. (Chappaqua, NY)
Assignee:
Filing Date:Mar 25, 1996
Application Number:08/623,892
Claims:1. A method for the treatment of a patient suffering from chronic insomnia comprising administering to said patient a compound selected from the group consisting of the pharmaceutically acceptable forms of amitriptyline, trimipramine, trazodone and mixtures thereof in a daily dosage ranging from about 0.5 to about 20 milligrams.

2. The method of claim 1 wherein the pharmaceutically acceptable form of amitriptyline, trazodone and mixtures thereof are the hydrochloride salts thereof and the pharmaceutically acceptable for of trimipramine is the maleate salt.

3. The method of claim 1 wherein the dosage of amitriptyline, trimipramine and mixtures thereof is about 10 milligrams or less.

4. The method of claim 3 wherein the dosage is about 5 milligrams or less.

5. The method of claim 1 wherein the compound is amitriptyline.

6. The method of claim 5 wherein the dosage is about 10 milligrams or less.

7. The method of claim 5 wherein the dosage is about 5 milligrams or less.

8. The method of claim 1 wherein the compound is trimipramine.

9. The method of claim 8 wherein the dosage is about 10 milligrams or less.

10. The method of claim 8 wherein the dosage is about 5 milligrams or less.

11. The method of claim 1 wherein the compound is trazodone.

12. The method of claim 11 wherein the dosage of trazodone ranges from about 5 to about 15 milligrams.

13. The method of claim 1 wherein the patient is not suffering from depression.

14. The method of claim 1 wherein the patient is suffering from depression.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Argus Health
US Department of Justice
Cipla
Teva
Moodys
Baxter
Covington
UBS
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot